Dr Ronald Tynes
BRCCH Consortium Member
University of Applied Sciences and Arts Northwestern Switzerland
Dr Ronald Tynes is a scientist at the Institute of Chemistry and Bioanalytics (ICB) at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) in Muttenz. Dr Tynes and his team will be supporting the DAVINCI team with the isolation and purification of COVID-19 antibodies from saliva and blood samples and with the development of a lateral flow assay to detect COVID-19 antibodies in saliva.
Dr Tynes’ research interests include diagnostics biochemistry and biotechnology. He received his PhD in biochemistry and toxicology from the North Carolina State University in the USA in 1984, followed by postdoctoral fellowships at the National Institutes of Health (USA) and Ciba-Geigy AG (Switzerland). His employment experience includes pharmaceuticals R&D at Sandoz AG and Novartis AG in Switzerland, as well as involvement in two start-up companies. He has been at the FHNW since 2008.